Boussiotis VA - Search Results

1

IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL.

Barata JT, Boussiotis VA, Yunes JA, Ferrando AA, Moreau LA, Veiga JP, Sallan SE, Look AT, Nadler LM, Cardoso AA. Barata JT, et al. Among authors: boussiotis va. Blood. 2004 Mar 1;103(5):1891-900. doi: 10.1182/blood-2002-12-3861. Epub 2003 Nov 13. Blood. 2004. PMID: 14615384 Free article.

2

Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.

Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM. Boussiotis VA, et al. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11059-63. doi: 10.1073/pnas.90.23.11059. Proc Natl Acad Sci U S A. 1993. PMID: 7504293 Free PMC article.

3

Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.

Salles G, Zain M, Jiang WM, Boussiotis VA, Shipp MA. Salles G, et al. Among authors: boussiotis va. Blood. 1993 Dec 15;82(12):3539-47. Blood. 1993. PMID: 7505117 Free article.

4

Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells.

Boussiotis VA, Nadler LM, Strominger JL, Goldfeld AE. Boussiotis VA, et al. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7007-11. doi: 10.1073/pnas.91.15.7007. Proc Natl Acad Sci U S A. 1994. PMID: 7518925 Free PMC article.

5

Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity.

Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM. Guinan EC, et al. Among authors: boussiotis va. Blood. 1994 Nov 15;84(10):3261-82. Blood. 1994. PMID: 7524733 Free article. Review.

6

CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy.

Boussiotis VA, Freeman GJ, Griffin JD, Gray GS, Gribben JG, Nadler LM. Boussiotis VA, et al. J Exp Med. 1994 Nov 1;180(5):1665-73. doi: 10.1084/jem.180.5.1665. J Exp Med. 1994. PMID: 7525835 Free PMC article.

7

Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance.

Boussiotis VA, Gribben JG, Freeman GJ, Nadler LM. Boussiotis VA, et al. Curr Opin Immunol. 1994 Oct;6(5):797-807. doi: 10.1016/0952-7915(94)90087-6. Curr Opin Immunol. 1994. PMID: 7530013 Review.

8

B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert PD, Gray GS, Gribben JG, Nadler LM. Freeman GJ, et al. Among authors: boussiotis va. Immunity. 1995 May;2(5):523-32. doi: 10.1016/1074-7613(95)90032-2. Immunity. 1995. PMID: 7538442 Free article.

9

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, Nadler LM. Freeman GJ, et al. Among authors: boussiotis va. Science. 1993 Nov 5;262(5135):909-11. doi: 10.1126/science.7694363. Science. 1993. PMID: 7694363

10

B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.

Boussiotis VA, Freeman GJ, Gray G, Gribben J, Nadler LM. Boussiotis VA, et al. J Exp Med. 1993 Nov 1;178(5):1753-63. doi: 10.1084/jem.178.5.1753. J Exp Med. 1993. PMID: 7901318 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters